Immunosuppressive treatment in asthma.
Kon
O M
OM
Royal Brompton Hospital, London.
Barnes
N
N
D001249:Asthma / Q000628:therapy*; D001379:Azathioprine / Q000627:therapeutic use; D002908:Chronic Disease; D018849:Controlled Clinical Trials as Topic; D018592:Cross-Over Studies; D016572:Cyclosporine / Q000276:immunology / Q000627:therapeutic use; D006046:Gold / Q000276:immunology / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000276:immunology / Q000627:therapeutic use*; D008727:Methotrexate / Q000276:immunology / Q000627:therapeutic use; D018579:Patient Selection; D013601:T-Lymphocytes
D016756:Immunoglobulins, Intravenous; D007166:Immunosuppressive Agents; D006046:Gold; D016572:Cyclosporine; D001379:Azathioprine; D008727:Methotrexate